300791SZSE

Verification Opinion from the Board of Directors' Compensation and Assessment Committee on the Repurchase and Cancellation of Restricted Stocks Granted but Not Yet Released from the 2023 and 2025 Restricted Stock Incentive Plans

Sirio Pharma Co., Ltd.·

Full Translation